FP-10が三剤併用療法によるピロリ菌除菌率に及ぼす影響
基本情報
- NCT ID
- NCT00281047
- ステータス
- 不明
- 試験のフェーズ
- 第2/第3相
- 試験タイプ
- 介入
- 目標被験者数
- 138
- 治験依頼者名
- Hamamatsu University
概要
FP-10 is a food ingredient derived from milk casein. FP-10 can inhibit H. pylori to attach to the gastric epithelium. FP-10 has been made clear to decrease the intragastric urease activity (which is assumed to be produced by H. pylori) measured by the urea breath test. FP-10 can also detach H. pylori from gastric epithelium. We have hypothesized that FP-10 increases the eradication rates by a triple therapy with a proton pump inhibitor, amoxicillin, and clarithromycin.
対象疾患
介入
依頼者(Sponsor)
実施施設 (6)
大分内科腎クリニック
Ōita, Oita Prefecture, Japan(RECRUITING)
松下クリニック
Hamamatsu, Shizuoka, Japan(RECRUITING)
かとう泌尿器科・内科・外科クリニック
Hamamatsu, Shizuoka, Japan(RECRUITING)
Oita Kouseiren Tsurumi Hospital
Beppu, Oita Prefecture, Japan(RECRUITING)
中島医院
Kakegawa, Shizuoka, Japan(RECRUITING)
University Hospital of Hamamatsu University School of Medicine
Hamamatsu, Shizuoka, Japan(RECRUITING)